27.05.2014
- In a move widely expected, Pfizer abandoned its attempt to buy AstraZeneca for nearly £70 billion ($118 billion) on May 26 as a final deadline mandated by British law approached...
23.05.2014
- Some leading AstraZeneca shareholders were at odds over whether the British drugmaker made the right decision in rejecting Pfizer's final $118 billion bid to buy the company, news...
20.05.2014
- AstraZeneca's share price tumbled by a double-digit margin on the London stock exchange after it was revealed the UK drugmaker had rejected Pfizer's latest offer - which the US...
15.05.2014
- AstraZeneca's chief executive Pascal Soriot said in an interview with the news agency Reuters he would engage with Pfizer if the price was right and the risks posed from forcing...
12.05.2014
- U.S. drugmaker Pfizer has dismissed criticism that its planned takeover of rival AstraZeneca would damage Britain's science base, saying strong UK research was a key reason for the...
08.05.2014
- British prime minister David Cameron has called on U.S. drugmaker Pfizer to give stronger guarantees it will keep jobs and investment in the UK if it is to secure his government's...
08.05.2014
- In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...
07.05.2014
- The UK could use its public interest powers to intervene in U.S. drugmaker Pfizer's potential takeover of British pharmaceutical firm AstraZeneca, Business Secretary Vince Cable...
